AwardedSVKGoods€792,747
Palivizumab
- Published
- Published 14 November 2025
- Deadline
- Closed 15 December 2025
Overview
Predmetom zákazky je humánny liek s názvom Palivizumab na plánované obdobie obstarávania 36 mesiacov.
Medicínsko-technická špecifikácia predmetu zákazky
Palivizumab 50mg/0,5ml:
• Typ položky: Humánny liek
• Liečivo + koncentrácia: Jedna 0,5ml injekčná liekovka obsahuje 50 mg palivizumabu. Palivizumab je rekombinantná humanizovaná monoklonálna protilátka vyrobená technológiou DNA v hostiteľských bunkách myelómu myší.
• ATC skupina: J06BD01
• Lieková forma: injekčný roztok
• Požadovaný počet: 2700 balení = injekčných liekoviek
Key details
- Country
- SVK
- Status
- Awarded
- Category
- Goods
- Estimated value
- €792,747
- Procedure
- Open
- SME suitable
- Yes
- Published
- 14 November 2025
- Deadline
- Closed
Immune sera and immunoglobulins
Award outcome
- Awarded value
- €792,746
- Award date
- 6 March 2026
- Contract period
- — → 18 February 2029
- UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
16 March 2026
Contract Notice
14 November 2025
Contracting authority
Národný ústav srdcových a cievnych chorôb, a.s.
Procuring entityBratislava, SVK
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.